insights_auto
Why is PGEN up 4.02%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$8.54
arrow_upward
+4.02%(+0.33) 1D
$8.57
arrow_upward
+0.39% (+0.034)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$8.30
High
$8.55
Low
$8.18
Mkt. cap
3.06B
Avg. vol.
4.78M
Volume
6.36M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
Open
$8.30
High
$8.55
Low
$8.18
Mkt. cap
3.06B
Avg. vol.
4.78M
Volume
6.36M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Zacks
·
23 hours ago
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
Zacks
·
2 days ago
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?
Seeking Alpha
·
2 days ago
Precigen: FDA’s Platform Technology Designation And Institutional Crossover Effect (PGEN)
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com
Analyst ratings
Based on 2 analysts giving stock ratings to PGEN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PGEN in the last 3 months.
Highest
Current $8.54
$18.00 (+110.77%)
Average
$15.00 (+75.64%)
Lowest
$12.00 (+40.52%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Swayampakula Ramakanth H.C. Wainwright | Buy | Reiterated | $18.00 | +110.8% | 10/01/2026 |
Yuan Zhi B. Riley Securities | Buy | Initiated | $12.00 | +40.5% | 09/25/2026 |
Jason Butler Citizens JMP | Buy | Maintained | $11.00 | +28.8% | 05/14/2026 |
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
- /
Revenue / Est. (USD)
54.98M / 27.83M
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.92M | 4.56M | 23.25M | 54.98M |
Cost of goods sold | 13.41M | 8.59M | 8.20M | 10.09M |
Cost of revenue | 13.41M | 8.59M | 8.20M | 10.09M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 23.99M | 17.64M | 21.05M | 22.25M |
Operating expense | 23.99M | 17.64M | 21.05M | 22.25M |
Total operating expenses | 37.40M | 26.23M | 29.25M | 32.34M |
Operating income | -34.48M | -21.67M | -5.99M | 22.64M |
Other non operating income | -111.50M | 60.00K | 290.00K | 16.00K |
EBT including unusual items | -146.34M | -23.50M | -7.93M | 20.07M |
EBT excluding unusual items | -146.34M | -23.50M | -7.93M | 20.07M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -146.34M | -23.50M | -7.93M | 20.07M |
Net profit margin | -5,008.35% | -514.85% | -34.10% | 36.51% |
Earnings per share | - | - | - | - |
Interest and investment income | 534.00K | 1.07M | 683.00K | 366.00K |
Interest expense | -902.00K | -2.96M | -2.91M | -2.95M |
Net interest expenses | -368.00K | -1.90M | -2.22M | -2.59M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -33.68M | -20.53M | -4.90M | 23.74M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1